Robert Klein, chairman of the California Institute for Regenerative Medicine will address the symposium on April 26.
Jesse Blout, Executive Director, Mayor's Office of Workforce and Economic Development, will address the symposium on April 26.
Anders Björklund, MD, PhD, Prof., Wallenberg Neuroscience Center, Division of Neurobiology, Lund University. Title: "Use of Stem Cells for Cell Replacement Therapy in Parkinson's Disease." View complete profile.
Lars Ährlund-Richter, PhD, Prof., Director, Unit of Molecular Embryology, Clinical Research Centre, Karolinska Institutet. Title: "Challenges for Achieving Clinically Eligible Cells." View complete profile.
Arnold R. Kriegstein, MD, PhD, Prof., Director, Program in Development and Stem Cell Biology, UCSF School of Medicine. Title: "Developmental Biology as the Foundation for Stem Cell Research." View complete profile.
Jane Lebkowski, PhD, Senior Vice President of Tissue Regenerative Medicine, Geron Corporation. Title: "Development of Human Embryonic Cell Based Therapeutics for the Treatment of Human Degenerative Diseases." View complete profile.
Henrik Semb, PhD, Prof. of Functional Genetics, Lund University, Co-Founder of Cellartis AB . Title: "Human Embryonic Stem Cells-Future Potential in Curative Medicine with Diabetes as an Example." View complete profile.
Sten Eirik W. Jacobsen, MD, PhD, Prof. Of Stem Cell Biology, Head Hematopoietic Stem Cell Laboratory, Director, Lund Stem Cell Center, Lund University. Title: "Role of Cytokines in Regulation of Hematopoietic Stem Cell Fate and Blood Lineage Development". Complete profile soon to come.
Ernest Arenas, MD, PhD, Prof., Laboratory of Molecular Neurobiology, Karolinska Institutet. Founder and Board member of NeuroTherapeutics AB. Title: "Engineering a Dopaminergic Phenotype in Stem Cells."
Outi Hovatta, Prof., Karolinska Institute, Department of Clinical Obstetrics and Gynaecology, Huddinge University Hospital.
Anders Haegerstrand, M.D., Ph.D., Vice President and Chief Scientific Officer, Neuronova. Title: "Pioneering Therapeutic Neurogenesis, Idea to Proof-of-Concept".
Anders Vedin, MD, PhD, Founder, Vedicon Consultancy, Co-founder and Chairman of the Board, Cellartis AB, Sweden. Title: "Commercialisation Of Radical Bio-Medical Innovation - Opportunity And Risk: The Case Of Human Embryonic Stem Cells."
Rik Derynck, Prof., Department of Cell and Tissue Biology Director, Program in Craniofacial and Mesenchymal Biology University of California at San Francisco. Title: "TGF-beta Family Signaling in Mesenchymal Differentiation".
Susan Fisher, PhD, Prof., Department of Cell and Tissue Biology, University of California San Francisco. Title: "Polarity as an important determinant of 'stemness'."
Michael German, MD, Prof., UCSF Diabetes Center at University of California San Francisco. Title: "Insulin Production From Stem Cells for the Treatment of Diabetes".
Bertram H. Lubin, MD, President and Director of Medical Research at Children’s Hospital of Oakland Research Institute (CHORI)
Deepa Pakianahthan, VC firm Delpi Ventures
Renee A. Reijo Pera, PhD, Co-Director, Program in Human Stem Cell Biology, University of California San Francisco. Title: "Human Embryonic Stem Cell-Derived Germ Cells".
David Warburton, DSc, MD, Prof., USC Keck School of Medicine and School of Dentistry, Leader, Developmental Biology Program, Childrens Hospital Los Angeles Saban Research Institute. Title: "Stem Cells in Organ Repair and Regeneration".
Irving L. Weissman, Founder, Sem Cells Inc., M.D., Professor of CancerBiology and Professor of Biological Sciences (invited).
John Wetherell, IP Lawyer, Pillsbury Winthrop Shaw Pittman LLP
Dr. Bertram H. Lubin, MD, President and Director of Medical Research at Children's Hospital of Oakland Research Institute (CHORI)
H. Ralph Snodgrass, Phd, CEO, VistaGen Therapeutics, Inc. Title: "Embryonic Stem Cells: Powerful New Tools for Drug Discovery and Development".
